Börsiteade
AS PRFoods
LEI kood
529900PFXFO2ZDCRNK93
Emitendi suuruskategooria
Keskmise suurusega kontsern
Majandustegevusalad
Finants- ja kindlustustegevus
Emitendi registreeritud asukoht
Eesti
Üldandmed
Kategooriad
Juhtkonna vaheteadaanne või kvartaalne finantsaruanne
Teate ID
8832
Manused
Esitamise kuupäev ja aeg
23.05.2021 23:32:53
Teate sisu eesti keeles
Pealkiri
AS-i PRFoods 2020/2021 majandusaasta 3. kvartali ja üheksa kuu konsolideeritud auditeerimata vahearuanne
Teade
JUHTKONNA KOMMENTAAR PRFoods ajaloo kõige keerulisem aasta hakkab lõppema. Koroonakriisi II laine kestis kauem kui eeldati ning sisuliselt oleme kogu käesoleva majandusaasta, mis lõppeb juunis, tegutsenud piirangute olukorras. Suletud on olnud HoReCa, pärsitud on ekspordi logistika ning tooraine turul oli Norra kalakasvatajad paanikas ning müüsid ajalooliselt madalate hindadega lõhet, mis viis kogu turu langusele. Kõik see väljendub ka meie majandustulemustes. Kahjuks peame tunnistama, et eelmine juhtkond tegi ka vigu investeeringutel ning ei suutnud reageerida piisavalt kiiresti muutunud olukorrale, mistõttu eriti Soomes võimendus koroona negatiivne mõju. Suurbritannia tegevus on jätkuvalt kasumlik ja aasta algusega on taastunud koroonaeelne kasumlikkus ning näeme väga tugevat kasvu nii käibes kui kasumis järgmisel finantsaastal. Eesti tegevus on veel väike, aga samas oleme jaekaubanduses suutnud kahekordistada oma käivet. Suure käibevolatiilsusega, kuid samas madalamarginaalne lõhe vahendus on olnud suures languses koroona ning maailmaturu rekordiliselt madalate hindade tõttu. Positiivne on asjaolu, et hoolimata piirangutest ning 23% väiksemast käibest, suutsime lõpetada finantsaasta 3 kvartali (jaanuar-märts) sama või isegi parema tulemusega kui aasta tagasi, arvestades, et jaanuar-märts 2020 olid tavapärased kuud, aga jaanuar-märts 2021 oli veel sügav koroonakriis Euroopas. Samas on see olnud meie jaoks üks positiivsemaid aastaid, sest oleme suutnud oma kauaaegse strateegia, muutuda regiooni üheks suuremaks kalakasvatajaks, viinud tegelikkusele lähemale. Uued kasvatusload Rootsis ning potentsiaalsed load Eestis võivad tähendada lähiaastatel 30-50 miljoni eurot suurust lisakäivet. Oleme arvestanud, et suure tõenäosusega võivad tulla piirangud taas sügisel. Tegeleme ettevõtte finantsvõimenduse vähendusega, mistõttu viime läbi konverteeritavate võlakirjade emissiooni. Ligikaudu pool meie laenudest on võetud John Ross Jr ostmistehingu läbiviimiseks ning John Ross Jr tulemused pole oluliselt kannatanud koroona tõttu, seega on olukord aktsepteeritav. Kalakasvatus nõuab pikaajalist kapitali kalasööda ostmiseks, millega tegeleme. Oleme vähendanud käibekapitali osakaalu tavaoperatsioonides, vähendades meie laojääke. Kõige olulisem on taastada ettevõtte kasumlikkus vähendatud käibe olukorras. VÕTMENÄITAJAD KASUMIARUANNE +--------------+---------+---------+---------+--------+--------+--------+--------+--------+ |mln EUR |1kv 2021 |4kv 2020 |3kv 2020 |2kv 2020|1kv 2020|4kv 2019|3kv 2019|2kv 2019| +--------------+---------+---------+---------+--------+--------+--------+--------+--------+ |Müügitulu | 14,2| 17,0| 12,7| 15,1| 18,5| 25,4| 19,3| 21,5| +--------------+---------+---------+---------+--------+--------+--------+--------+--------+ |Brutokasum | 0,9| 2,5| 1,2| 0,7| 2,0| 4,3| 2,6| 2,1| +--------------+---------+---------+---------+--------+--------+--------+--------+--------+ |EBITDA | | | | | | | | | |äritegevusest | -0,5| 0,6| -0,3| -0,4| 0,0| 2,1| 0,7| 0,3| +--------------+---------+---------+---------+--------+--------+--------+--------+--------+ |EBITDA | -0,7| 0,7| -0,5| -0,4| -0,9| 1,4| 1,5| 0,3| +--------------+---------+---------+---------+--------+--------+--------+--------+--------+ |EBIT | -1,4| 0,0| -1,1| -1,0| -1,4| 0,7| 1,0| -0,3| +--------------+---------+---------+---------+--------+--------+--------+--------+--------+ |EBT | -1,8| -0,1| -1,4| -1,2| -1,8| 0,6| 0,8| -0,4| +--------------+---------+---------+---------+--------+--------+--------+--------+--------+ |Puhaskasum (- | | | | | | | | | |kahjum) | -1,8| -0,2| -1,4| -1,3| -1,7| 0,5| 0,6| -0,6| +--------------+---------+---------+---------+--------+--------+--------+--------+--------+ |Brutomarginaal| 6,6%| 14,9%| 9,4%| 4,6%| 10,8%| 17,0%| 13,4%| 9,8%| +--------------+---------+---------+---------+--------+--------+--------+--------+--------+ |Äritegev. | | | | | | | | | |EBITDA | | | | | | | | | |marginaal | -3,5%| 3,4%| -2,6%| -2,6%| 0,1%| 8,4%| 3,8%| 1,4%| +--------------+---------+---------+---------+--------+--------+--------+--------+--------+ |EBITDA | | | | | | | | | |marginaal | -5,3%| 4,1%| -3,8%| -2,6%| -4,6%| 5,3%| 7,6%| 1,4%| +--------------+---------+---------+---------+--------+--------+--------+--------+--------+ |EBIT marginaal| -9,9%| 0,2%| -8,8%| -6,4%| -7,8%| 2,9%| 5,0%| -1,2%| +--------------+---------+---------+---------+--------+--------+--------+--------+--------+ |EBT marginaal | -12,5%| -0,6%| -11,3%| -8,1%| -9,8%| 2,2%| 3,9%| -2,0%| +--------------+---------+---------+---------+--------+--------+--------+--------+--------+ |Puhaskasumi | | | | | | | | | |marginaal | -12,5%| -1,2%| -11,3%| -8,4%| -9,2%| 2,0%| 2,9%| -3,0%| +--------------+---------+---------+---------+--------+--------+--------+--------+--------+ |Tegevuskulude | | | | | | | | | |suhtarv | 15,6%| 15,6%| 18,2%| 13,9%| 14,3%| 12,5%| 13,4%| 11,7%| +--------------+---------+---------+---------+--------+--------+--------+--------+--------+ BILANSS +-----------------+----------+----------+----------+----------+----------+----------+----------+ |mln EUR |31.03.2021|31.12.2020|30.09.2020|30.06.2020|31.03.2020|31.12.2019|30.09.2019| +-----------------+----------+----------+----------+----------+----------+----------+----------+ |Netovõlgnevus | 21,4| 21,9| 21,5| 20,7| 17,0| 17,8| 19,9| +-----------------+----------+----------+----------+----------+----------+----------+----------+ |Omakapital | 17,6| 18,6| 18,5| 19,8| 21,6| 23,3| 22,8| +-----------------+----------+----------+----------+----------+----------+----------+----------+ |Käibekapital | -5,0| -3,9| -4,4| -4,0| -2,5| -3,5| -3,0| +-----------------+----------+----------+----------+----------+----------+----------+----------+ |Varad | 54,5| 57,5| 57,4| 57,1| 56,9| 60,5| 62,4| +-----------------+----------+----------+----------+----------+----------+----------+----------+ |Likviidsuskordaja| 0,8x| 0,8x| 0,8x| 0,8x| 0,9x| 0,9x| 0,9x| +-----------------+----------+----------+----------+----------+----------+----------+----------+ |Omakapitali | | | | | | | | |suhtarv | 32,4%| 32,4%| 32,3%| 34,7%| 37,9%| 38,5%| 36,5%| +-----------------+----------+----------+----------+----------+----------+----------+----------+ |Finantsvõimendus | 54,9%| 54,0%| 53,7%| 51,1%| 44,0%| 43,3%| 46,6%| +-----------------+----------+----------+----------+----------+----------+----------+----------+ |Võlakordaja | 0,7x| 0,7x| 0,7x| 0,7x| 0,6x| 0,6x| 0,6x| +-----------------+----------+----------+----------+----------+----------+----------+----------+ |Netovõlg / EBITDA| | | | | | | | |äriteg | -55,3x| 160,0x| 12,8x| 7,5x| 5,3x| 5,3x| 5,4x| +-----------------+----------+----------+----------+----------+----------+----------+----------+ |Omakapitali | | | | | | | | |tootlus | -23,8%| -21,9%| -7,0%| -9,1%| -5,7%| -3,2%| -4,5%| +-----------------+----------+----------+----------+----------+----------+----------+----------+ |Varade tootlus | -8,4%| -7,8%| -2,4%| -3,2%| -2,1%| -1,2%| -1,6%| +-----------------+----------+----------+----------+----------+----------+----------+----------+ Konsolideeritud finantsseisundi aruanne +-------------------------------------+------------+------------+------------+ | Tuhandetes eurodes | 31.03.2021 | 31.03.2020 | 30.06.2020 | +-------------------------------------+------------+------------+------------+ | VARAD | | | | +-------------------------------------+------------+------------+------------+ | Raha ja ekvivalendid | 1 485 | 3 023 | 2 276 | +-------------------------------------+------------+------------+------------+ | Nõuded ja ettemaksed | 3 536 | 4 095 | 3 578 | +-------------------------------------+------------+------------+------------+ | Varud | 7 645 | 9 656 | 7 884 | +-------------------------------------+------------+------------+------------+ | Bioloogilised varad | 2 366 | 2 590 | 4 249 | +-------------------------------------+------------+------------+------------+ | Käibevara kokku | 15 032 | 19 364 | 17 987 | +-------------------------------------+------------+------------+------------+ | | | | | +-------------------------------------+------------+------------+------------+ | Edasilükkunud tulumaksuvara | 21 | 18 | 54 | +-------------------------------------+------------+------------+------------+ | Pikaajalised finantsinvesteeringud | 232 | 215 | 232 | +-------------------------------------+------------+------------+------------+ | Materiaalne põhivara | 15 541 | 14 135 | 16 179 | +-------------------------------------+------------+------------+------------+ | Immateriaalne vara | 23 626 | 23 208 | 22 672 | +-------------------------------------+------------+------------+------------+ | Põhivara kokku | 39 420 | 37 576 | 39 137 | +-------------------------------------+------------+------------+------------+ | VARAD KOKKU | 54 452 | 56 940 | 57 124 | +-------------------------------------+------------+------------+------------+ | | | | | +-------------------------------------+------------+------------+------------+ | KOHUSTUSED JA OMAKAPITAL | | | | +-------------------------------------+------------+------------+------------+ | Intressikandvad kohustused | 8 984 | 9 518 | 10 611 | +-------------------------------------+------------+------------+------------+ | Võlad ja ettemaksed | 10 833 | 12 142 | 11 132 | +-------------------------------------+------------+------------+------------+ | Sihtfinantseerimine | 208 | 187 | 211 | +-------------------------------------+------------+------------+------------+ | Lühiajalised kohustused kokku | 20 025 | 21 847 | 21 954 | +-------------------------------------+------------+------------+------------+ | | | | | +-------------------------------------+------------+------------+------------+ | Intressikandvad kohustused | 13 944 | 10 489 | 12 368 | +-------------------------------------+------------+------------+------------+ | Võlad ja ettemaksed | 298 | 190 | 190 | +-------------------------------------+------------+------------+------------+ | Edasilükkunud tulumaksukohustus | 1 787 | 1 854 | 1 920 | +-------------------------------------+------------+------------+------------+ | Sihtfinantseerimine | 752 | 962 | 873 | +-------------------------------------+------------+------------+------------+ | Pikaajalised kohustused kokku | 16 781 | 13 495 | 15 351 | +-------------------------------------+------------+------------+------------+ | KOHUSTUSED KOKKU | 36 806 | 35 342 | 37 305 | +-------------------------------------+------------+------------+------------+ | | | | | +-------------------------------------+------------+------------+------------+ | Aktsiakapital | 7 737 | 7 737 | 7 737 | +-------------------------------------+------------+------------+------------+ | Ülekurss | 14 198 | 14 007 | 14 007 | +-------------------------------------+------------+------------+------------+ | Oma aktsiad | -390 | -390 | -390 | +-------------------------------------+------------+------------+------------+ | Kohustuslik reservkapital | 51 | 51 | 51 | +-------------------------------------+------------+------------+------------+ | Realiseerimata kursivahed | 683 | 147 | -366 | +-------------------------------------+------------+------------+------------+ | Jaotamata kasum (kahjum) | -4 985 | -550 | -1 654 | +-------------------------------------+------------+------------+------------+ | Ettevõtte aktsionäridele kuuluv osa | 17 294 | 21 002 | 19 385 | +-------------------------------------+------------+------------+------------+ | Mittekontrolliv osalus | 352 | 596 | 434 | +-------------------------------------+------------+------------+------------+ | OMAKAPITAL KOKKU | 17 646 | 21 598 | 19 819 | +-------------------------------------+------------+------------+------------+ | OMAKAPITAL JA KOHUSTUSED KOKKU | 54 452 | 56 940 | 57 124 | +-------------------------------------+------------+------------+------------+ Konsolideeritud koondkasumiaruanne +------------------------+-------------+-------------+------------+------------+ |Tuhandetes eurodes |3kv 2020/2021|3kv 2019/2020|9k 2020/2021|9k 2019/2020| +------------------------+-------------+-------------+------------+------------+ |Müügitulud | 14 186| 18 488| 43 952| 63 191| +------------------------+-------------+-------------+------------+------------+ |Müüdud kaupade kulu | -13 247| -16 497| -39 280| -54 293| +------------------------+-------------+-------------+------------+------------+ |Brutokasum | 939| 1 991| 4 672| 8 898| +------------------------+-------------+-------------+------------+------------+ | | | | | | +------------------------+-------------+-------------+------------+------------+ |Tegevuskulud | -2 219| -2 635| -7 204| -8 402| +------------------------+-------------+-------------+------------+------------+ | Turundus- ja | | | | | |müügikulud | -1 523| -1 735| -4 890| -5 673| +------------------------+-------------+-------------+------------+------------+ | Üldhalduskulud | -696| -900| -2 314| -2 729| +------------------------+-------------+-------------+------------+------------+ |Muud äritulud/-kulud | 26| -35| 163| 299| +------------------------+-------------+-------------+------------+------------+ |Bioloogiliste varade | | | | | |ümberhindlus | -154| -754| -130| -530| +------------------------+-------------+-------------+------------+------------+ |Ärikasum (-kahjum) | -1 408| -1 433| -2 499| 265| +------------------------+-------------+-------------+------------+------------+ | Finantstulud/-kulud | -370| -384| -808| -777| +------------------------+-------------+-------------+------------+------------+ |Maksustamiseelne kasum | | | | | |(-kahjum) | -1 778| -1 817| -3 307| -512| +------------------------+-------------+-------------+------------+------------+ | Tulumaks | -1| 120| -106| -119| +------------------------+-------------+-------------+------------+------------+ |Aruandeperioodi | | | | | |puhaskasum (-kahjum) | -1 779| -1 697| -3 413| -631| +------------------------+-------------+-------------+------------+------------+ | | | | | | +------------------------+-------------+-------------+------------+------------+ |Aruandeperioodi | | | | | |puhaskasumi (-kahjum) | | | | | |jaotus: | | | | | +------------------------+-------------+-------------+------------+------------+ |emaettevõtte | | | | | |aktsionäridele kuuluv | | | | | |osa | -1 739| -1 658| -3 331| -616| +------------------------+-------------+-------------+------------+------------+ |Väikeaktsionäridele | | | | | |kuuluv osa | -40| -39| -82| -15| +------------------------+-------------+-------------+------------+------------+ |Aruandeperioodi | | | | | |puhaskasumi (-kahjum) | | | | | |kokku | -1 779| -1 697| -3 413| -631| +------------------------+-------------+-------------+------------+------------+ | | | | | | +------------------------+-------------+-------------+------------+------------+ |Muu koondkasum (- | | | | | |kahjum), mida võib | | | | | |hiljem klassifitseerida | | | | | |kasumiaruandesse: | | | | | +------------------------+-------------+-------------+------------+------------+ |Valuutakursi vahed | 781| -20| 1 049| 361| +------------------------+-------------+-------------+------------+------------+ |Kokku koondkasum (- | | | | | |kahjum) | -998| -1 717| -2 364| -270| +------------------------+-------------+-------------+------------+------------+ | | | | | | +------------------------+-------------+-------------+------------+------------+ |Aruandeperioodi | | | | | |koondkasumi (-kahjum) | | | | | |jaotus: | | | | | +------------------------+-------------+-------------+------------+------------+ |emaettevõtte | | | | | |aktsionäridele kuuluv | | | | | |osa | -958| -1 678| -2 282| -255| +------------------------+-------------+-------------+------------+------------+ |Väikeaktsionäridele | | | | | |kuuluv osa | -40| -39| -82| -15| +------------------------+-------------+-------------+------------+------------+ |Aruandeperioodi | | | | | |koondkasum (-kahjum) | | | | | |kokku | -998| -1 717| -2 364| -270| +------------------------+-------------+-------------+------------+------------+ | | | | | | +------------------------+-------------+-------------+------------+------------+ |Tava puhaskasum (- | | | | | |kahjum) aktsia kohta | | | | | |(EUR) | -0,04| -0,04| -0,09| -0,02| +------------------------+-------------+-------------+------------+------------+ | | | | | | +------------------------+-------------+-------------+------------+------------+ |Lahustatud puhaskasum (-| | | | | |kahjum) aktsia kohta | | | | | |(EUR) | -0,04| -0,04| -0,09| -0,02| +------------------------+-------------+-------------+------------+------------+ Indrek Kasela AS PRFoods Juhatuse liige T: +372 452 1470 [email protected] www.prfoods.ee
Teate sisu inglise keeles
Pealkiri
Consolidated Unaudited Interim Report of AS PRFoods for the 3nd quarter and 9 months of 2020/2021 financial year
Teade
MANAGEMENT COMMENTARY The most difficult year in PRFoods history is coming to close. Second wave of corona crisis lasted longer than predicted and in reality we have operated under restrictions the entire financial year ending in June. HoReCa has been closed, export logistics has been hindered and Norwegian salmon farmers dumped salmon at record low prices, that led to decrease of entire market. All this is reflected in our financial performance. Unfortunately we must admit that previous management made mistakes in investments and did not react to changed environment fast enough in Finland, thus amplifying the negatiive effect of corona. UK operations have been consistently profitable and from the beginning of calendar year we have resumed pre-coroan profitability and we see strong growth in sales and profitability for next financial year. Estonian operations are still small, but at the samet ime we doubled our retail sales on y-o-y. Fresh salmon trading, characterised by high sales volatility , but small margins, has been in very substantial decline due to corona and record low prices. On positive side we managed to end Q3 with same result as last year despite -23% in sales, considering that January-March 2020 were normal months, but January- March 2021, Europe was still thick in corona crisis. At the same time it has been one of the most positive years for us, as we got much closer in our strategy to become one of the biggest fish farmers in the region. New farming permits in Sweden and potential new permits in Estonia could contribute to 30-50 million euros additional sales in coming years. We are prepared that there will be new corona-related restrictions in fall 2021. We also deal actively with deleveraging the company, carrying out new issue of convertible bonds. Ca half of our loans are related to acquisition finance of John Ross Jr. , and their results have not been materially affected by corona, meaning the leverage is acceptable. Fish farming requires long-term financing and we are investigating alternatives. We have reduced the need of working capital in processing, decreasing our inventory levels. Most important is to restore profitability in the environment of decreased sales. KEY RATIOS INCOME STATEMENT +--------------+-------+-------+-------+-------+-------+-------+-------+-------+ |mln EUR |1Q 2021|4Q 2020|3Q 2020|2Q 2020|1Q 2020|4Q 2019|3Q 2019|2Q 2019| +--------------+-------+-------+-------+-------+-------+-------+-------+-------+ |Sales | 14.2| 17.0| 12.7| 15.1| 18.5| 25.4| 19.3| 21.5| +--------------+-------+-------+-------+-------+-------+-------+-------+-------+ |Gross profit | 0.9| 2.5| 1.2| 0.7| 2.0| 4.3| 2.6| 2.1| +--------------+-------+-------+-------+-------+-------+-------+-------+-------+ |EBITDA from | | | | | | | | | |operations | -0.5| 0.6| -0.3| -0.4| 0.0| 2.1| 0.7| 0.3| +--------------+-------+-------+-------+-------+-------+-------+-------+-------+ |EBITDA | -0.7| 0.7| -0.5| -0.4| -0.9| 1.4| 1.5| 0.3| +--------------+-------+-------+-------+-------+-------+-------+-------+-------+ |EBIT | -1.4| 0.0| -1.1| -1.0| -1.4| 0.7| 1.0| -0.3| +--------------+-------+-------+-------+-------+-------+-------+-------+-------+ |EBT | -1.8| -0.1| -1.4| -1.2| -1.8| 0.6| 0.8| -0.4| +--------------+-------+-------+-------+-------+-------+-------+-------+-------+ |Net profit (- | | | | | | | | | |loss) | -1.8| -0.2| -1.4| -1.3| -1.7| 0.5| 0.6| -0.6| +--------------+-------+-------+-------+-------+-------+-------+-------+-------+ |Gross margin | 6.6%| 14.9%| 9.4%| 4.6%| 10.8%| 17.0%| 13.4%| 9.8%| +--------------+-------+-------+-------+-------+-------+-------+-------+-------+ |Operational | | | | | | | | | |EBITDA margin | -3.5%| 3.4%| -2.6%| -2.6%| 0.1%| 8.4%| 3.8%| 1.4%| +--------------+-------+-------+-------+-------+-------+-------+-------+-------+ |EBITDA margin | -5.3%| 4.1%| -3.8%| -2.6%| -4.6%| 5.3%| 7.6%| 1.4%| +--------------+-------+-------+-------+-------+-------+-------+-------+-------+ |EBIT margin | -9.9%| 0.2%| -8.8%| -6.4%| -7.8%| 2.9%| 5.0%| -1.2%| +--------------+-------+-------+-------+-------+-------+-------+-------+-------+ |EBT margin | -12.5%| -0.6%| -11.3%| -8.1%| -9.8%| 2.2%| 3.9%| -2.0%| +--------------+-------+-------+-------+-------+-------+-------+-------+-------+ |Net margin | -12.5%| -1.2%| -11.3%| -8.4%| -9.2%| 2.0%| 2.9%| -3.0%| +--------------+-------+-------+-------+-------+-------+-------+-------+-------+ |Operating | | | | | | | | | |expense ratio | 15.6%| 15.6%| 18.2%| 13.9%| 14.3%| 12.5%| 13.4%| 11.7%| +--------------+-------+-------+-------+-------+-------+-------+-------+-------+ BALANCE SHEET +---------+----------+----------+----------+----------+----------+----------+----------+ |mln EUR |31.03.2021|31.12.2020|30.09.2020|30.06.2020|31.03.2020|31.12.2019|30.09.2019| +---------+----------+----------+----------+----------+----------+----------+----------+ |Net debt | 21.4| 21.9| 21.5 20.7| 17.0| 17.8| 19.9| +---------+----------+----------+---------------------+----------+----------+----------+ |Equity | 17.6| 18.6| 18.5 19.8| 21.6| 23.3| 22.8| +---------+----------+----------+---------------------+----------+----------+----------+ |Working | | | | | | | |capital | -5.0| -3.9| -4.4 -4.0| -2.5| -3.5| -3.0| +---------+----------+----------+---------------------+----------+----------+----------+ |Assets | 54.5| 57.5| 57.4 57.1| 56.9| 60.5| 62.4| +---------+----------+----------+---------------------+----------+----------+----------+ |Liquidity| | | | | | | |ratio | 0.8x| 0.8x| 0.8x 0.8x| 0.9x| 0.9x| 0.9x| +---------+----------+----------+---------------------+----------+----------+----------+ |Equity | | | | | | | |ratio | 32.4%| 32.4%| 32.3% 34.7%| 37.9%| 38.5%| 36.5%| +---------+----------+----------+---------------------+----------+----------+----------+ |Gearing | | | | | | | |ratio | 54.9%| 54.0%| 53.7% 51.1%| 44.0%| 43.3%| 46.6%| +---------+----------+----------+---------------------+----------+----------+----------+ |Debt to | | | | | | | |total | | | | | | | |assets | 0.7x| 0.7x| 0.7x 0.7x| 0.6x| 0.6x| 0.6x| +---------+----------+----------+---------------------+----------+----------+----------+ |Net debt | | | | | | | |to EBITDA| | | | | | | |op | -55.3x| 160.0x| 12.8x 7.5x| 5.3x| 5.3x| 5.4x| +---------+----------+----------+---------------------+----------+----------+----------+ |ROE | -23.8%| -21.9%| -7.0% -9.1%| -5.7%| -3.2%| -4.5%| +---------+----------+----------+---------------------+----------+----------+----------+ |ROA | -8.4%| -7.8%| -2.4% -3.2%| -2.1%| -1.2%| -1.6%| +---------+----------+----------+---------------------+----------+----------+----------+ Consolidated Statement of Financial Position +---------------------------------+------------+------------+------------+ | Thousand euros | 31.03.2021 | 31.03.2020 | 30.06.2020 | +---------------------------------+------------+------------+------------+ | ASSETS | | | | +---------------------------------+------------+------------+------------+ | Cash and cash equivalents | 1,485 | 3,023 | 2,276 | +---------------------------------+------------+------------+------------+ | Receivables and prepayments | 3,536 | 4,095 | 3,578 | +---------------------------------+------------+------------+------------+ | Inventories | 7,645 | 9,656 | 7,884 | +---------------------------------+------------+------------+------------+ | Biological assets | 2,366 | 2,590 | 4,249 | +---------------------------------+------------+------------+------------+ | Total current assets | 15,032 | 19,364 | 17,987 | +---------------------------------+------------+------------+------------+ | | | | | +---------------------------------+------------+------------+------------+ | Deferred income tax | 21 | 18 | 54 | +---------------------------------+------------+------------+------------+ | Long-term financial investments | 232 | 215 | 232 | +---------------------------------+------------+------------+------------+ | Tangible fixed assets | 15,541 | 14,135 | 16,179 | +---------------------------------+------------+------------+------------+ | Intangible assets | 23,626 | 23,208 | 22,672 | +---------------------------------+------------+------------+------------+ | Total non-current assets | 39,420 | 37,576 | 39,137 | +---------------------------------+------------+------------+------------+ | TOTAL ASSETS | 54,452 | 56,940 | 57,124 | +---------------------------------+------------+------------+------------+ | | | | | +---------------------------------+------------+------------+------------+ | EQUITY AND LIABILITIES | | | | +---------------------------------+------------+------------+------------+ | Loans and borrowings | 8,984 | 9,518 | 10,611 | +---------------------------------+------------+------------+------------+ | Payables | 10,833 | 12,142 | 11,132 | +---------------------------------+------------+------------+------------+ | Government grants | 208 | 187 | 211 | +---------------------------------+------------+------------+------------+ | Total current liabilities | 20,025 | 21,847 | 21,954 | +---------------------------------+------------+------------+------------+ | | | | | +---------------------------------+------------+------------+------------+ | Loans and borrowings | 13,944 | 10,489 | 12,368 | +---------------------------------+------------+------------+------------+ | Payables | 298 | 190 | 190 | +---------------------------------+------------+------------+------------+ | Deferred tax liabilities | 1,787 | 1,854 | 1,920 | +---------------------------------+------------+------------+------------+ | Government grants | 752 | 962 | 873 | +---------------------------------+------------+------------+------------+ | Total non-current liabilities | 16,781 | 13,495 | 15,351 | +---------------------------------+------------+------------+------------+ | TOTAL LIABILITIES | 36,806 | 35,342 | 37,305 | +---------------------------------+------------+------------+------------+ | | | | | +---------------------------------+------------+------------+------------+ | Share capital | 7,737 | 7,737 | 7,737 | +---------------------------------+------------+------------+------------+ | Share premium | 14,198 | 14,007 | 14,007 | +---------------------------------+------------+------------+------------+ | Treasury shares | -390 | -390 | -390 | +---------------------------------+------------+------------+------------+ | Statutory capital reserve | 51 | 51 | 51 | +---------------------------------+------------+------------+------------+ | Currency translation reserve | 683 | 147 | -366 | +---------------------------------+------------+------------+------------+ | Retained profit (-loss) | -4,985 | -550 | -1,654 | +---------------------------------+------------+------------+------------+ | Equity attributable to parent | 17,294 | 21,002 | 19,385 | +---------------------------------+------------+------------+------------+ | Non-controlling interest | 352 | 596 | 434 | +---------------------------------+------------+------------+------------+ | TOTAL EQUITY | 17,646 | 21,598 | 19,819 | +---------------------------------+------------+------------+------------+ | TOTAL EQUITY AND LIABILITIES | 54,452 | 56,940 | 57,124 | +---------------------------------+------------+------------+------------+ Consolidated Statement of Profit or Loss And Other Comprehensive Income +--------------------+------------+------------+---------------+---------------+ |Thousand euros | | | 9 months| 9 months| | |3Q 2020/2021|3Q 2019/2020| 2020/2021| 2019/2020| +--------------------+------------+------------+---------------+---------------+ |Sales | 14,186| 18,488| 43,952| 63,191| +--------------------+------------+------------+---------------+---------------+ |Cost of goods sold | -13,247| -16,497| -39,280| -54,293| +--------------------+------------+------------+---------------+---------------+ |Gross profit | 939| 1,991| 4,672| 8,898| +--------------------+------------+------------+---------------+---------------+ | | | | | | +--------------------+------------+------------+---------------+---------------+ |Operating expenses | -2,219| -2,635| -7,204| -8,402| +--------------------+------------+------------+---------------+---------------+ |Selling and | | | | | |distribution | | | | | |expenses | -1,523| -1,735| -4,890| -5,673| +--------------------+------------+------------+---------------+---------------+ |Administrative | | | | | |expenses | -696| -900| -2,314| -2,729| +--------------------+------------+------------+---------------+---------------+ |Other income / | | | | | |expense | 26| -35| 163| 299| +--------------------+------------+------------+---------------+---------------+ |Fair value | | | | | |adjustment on | | | | | |biological assets | -154| -754| -130| -530| +--------------------+------------+------------+---------------+---------------+ |Operating profit | | | | | |(loss) | -1,408| -1,433| -2,499| 265| +--------------------+------------+------------+---------------+---------------+ |Financial income/- | | | | | |expenses | -370| -384| -808| -777| +--------------------+------------+------------+---------------+---------------+ |Profit (loss) before| | | | | |tax | -1,778| -1,817| -3,307| -512| +--------------------+------------+------------+---------------+---------------+ |Income tax | -1| 120| -106| -119| +--------------------+------------+------------+---------------+---------------+ |Net profit (loss) | | | | | |for the period | -1,779| -1,697| -3,413| -631| +--------------------+------------+------------+---------------+---------------+ | | | | | | +--------------------+------------+------------+---------------+---------------+ |Net profit (loss) | | | | | |attributable to: | | | | | +--------------------+------------+------------+---------------+---------------+ |Owners of the | | | | | |company | -1,739| -1,658| -3,331| -616| +--------------------+------------+------------+---------------+---------------+ |Non-controlling | | | | | |interests | -40| -39| -82| -15| +--------------------+------------+------------+---------------+---------------+ |Total net profit | | | | | |(loss) | -1,779| -1,697| -3,413| -631| +--------------------+------------+------------+---------------+---------------+ | | | | | | +--------------------+------------+------------+---------------+---------------+ |Other omprehensive | | | | | |income (loss) that | | | | | |may subsequently be | | | | | |classified to profit| | | | | |or loss: | | | | | +--------------------+------------+------------+---------------+---------------+ |Foreign currency | | | | | |translation | | | | | |differences | 781| -20| 1,049| 361| +--------------------+------------+------------+---------------+---------------+ |Total comprehensive | | | | | |income (expense) | -998| -1,717| -2,364| -270| +--------------------+------------+------------+---------------+---------------+ | | | | | | +--------------------+------------+------------+---------------+---------------+ |Total comprehensive | | | | | |income (expense) | | | | | |attributable to: | | | | | +--------------------+------------+------------+---------------+---------------+ |Owners of the | | | | | |Company | -958| -1,678| -2,282| -255| +--------------------+------------+------------+---------------+---------------+ |Non-controlling | | | | | |interests | -40| -39| -82| -15| +--------------------+------------+------------+---------------+---------------+ |Total comprehensive | | | | | |income (expense) for| | | | | |the period | -998| -1,717| -2,364| -270| +--------------------+------------+------------+---------------+---------------+ | | | | | | +--------------------+------------+------------+---------------+---------------+ |Profit (loss) per | | | | | |share (EUR) | -0,04| -0,04| -0,09| -0,02| +--------------------+------------+------------+---------------+---------------+ | | | | | | +--------------------+------------+------------+---------------+---------------+ |Diluted profit | | | | | |(loss) per share | | | | | |(EUR) | -0,04| -0,04| -0,09| -0,02| +--------------------+------------+------------+---------------+---------------+ Indrek Kasela AS PRFoods Member of the Management Board Phone:+372 452 1470 [email protected] www.prfoods.ee